Article

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer

2024-02-23

Abstract excerpt

<h4>Introduction</h4> Determining lines of therapy (LOT) using real-world data is crucial to inform clinical decisions and support clinical research. Existing rules for determining LOT in patients with metastatic non-small cell lung cancer (mNSCLC) do not incorporate the growing number of targeted therapies used in treatment today. Therefore, we propose rules for determining LOT from real-world data of patients wi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2db4f65-66d4-5d76-aa0e-0c80356badc8
DOI: 10.1101/2024.02.22.24302979

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung CancerDOI 10.1101/2024.02.22.24302979Read

Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.Semantic proximity Read

Retrospective Analysis of Real-World Treatment Patterns and Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Starting First-Line Systemic Therapy in the United KingdomSemantic proximity Read

Treatment Patterns Across Lines of Therapy for Advanced Non-Small Cell Lung Cancer in the United States.Semantic proximity Read

First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need.Semantic proximity Read

Real-world treatment patterns and attrition for non-driver mutation metastatic non-small cell lung cancer in the US.Semantic proximity Read

Temporal phenotyping by mining healthcare data to derive lines of therapy for cancer.Semantic proximity Read

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.Semantic proximity Read

Mutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice.Semantic proximity Read

Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations.Semantic proximity Read

Molecular Pathology Testing for Non-small Cell Lung Cancer: An Observational Study of Elements Currently Present in Request Forms and Result Reports and The Opinion of Different StakeholdersSemantic proximity Read

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.Semantic proximity Read

Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study.Semantic proximity Read